We are international
• treatment options TEXT SIZE   
drugs & procedures in clinical trials    back

Understanding Kyprolis® (carfilzomib) for Injection

This booklet discusses Kyprolis® (carfilzomib), the results of clinical trials with Kyprolis, how and when Kyprolis is administered, and the possible side effects of Kyprolis and how to manage them. Kyprolis is in a new class of drugs called proteasome inhibitors. It works by blocking the activity of enzyme complexes called proteasomes. 



Be the first to comment

 related articles